Halozyme CEO to Present at Three Key Healthcare Conferences in March
Event summary
- Halozyme CEO Dr. Helen Torley to present at TD Cowen Healthcare Conference on March 3, 2026.
- Torley to host investor meetings at Leerink Partners Global Healthcare Conference on March 10, 2026.
- CEO to participate in The Citizens Life Sciences Conference on March 11, 2026.
- Live audio webcasts available on Halozyme's Investor Relations page.
- Replays of presentations available for 90 days post-conference.
The big picture
Halozyme's participation in these high-profile conferences underscores its strategic focus on expanding its drug delivery technology portfolio and strengthening partnerships with leading biopharmaceutical companies. The company's innovative solutions, such as ENHANZE®, Hypercon™, and Surf Bio, are positioned to disrupt traditional drug delivery methods, potentially reducing treatment burden and improving patient outcomes. The upcoming presentations will provide key insights into Halozyme's growth trajectory and its ability to capitalize on emerging opportunities in the healthcare sector.
What we're watching
- Strategic Partnerships
- How Halozyme's collaborations with major pharma companies will impact its market position and revenue streams.
- Technology Innovation
- The pace at which Hypercon™ and Surf Bio technologies will be commercialized and adopted by partners.
- Investor Sentiment
- Whether the upcoming presentations will shift investor perception and drive stock performance.